On‐demand deprescribing vs continued use: Participant satisfaction
It is very uncertain whether on‐demand deprescribing changes participant satisfaction compared with continued use (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
On‐demand deprescribing vs continued use Participant satisfaction · people with moderate GERD and mild esophagitis, mean age 48 to 57 years It is very uncertain whether on‐demand deprescribing changes participant satisfaction compared with continued use (very low certainty). Deprescribing versus continuation of chronic proton pump inhibitor use in adults (2017) · Cochrane Headline outcomes only | RR 1.82 [1.26, 2.65] | 5 studies · 1653 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Deprescribing versus continuation of chronic proton pump inhibitor use in adults 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.